NCT06907043
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06907043
Title A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors. (EIK1004-001)
Acronym EIK1004-001
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eikon Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthOne RECRUITING Denver Colorado 80218 United States Details
Florida Cancer Center RECRUITING Lake Mary Florida 32746 United States Details
Beth Israel Deaconess Medical Center RECRUITING Boston Massachusetts 02215 United States Details
MD Anderson RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
PASO Medical RECRUITING Frankston Victoria 3199 Australia Details
Chongqing University Cancer Hospital RECRUITING Chongqing Chongqing Municipality 400030 China Details
Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute, Shandong Cancer Hospital) RECRUITING Jinan Shandong 250117 China Details
Fudan University Shanghai Cancer Center RECRUITING Shanghai China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field